Latest News

Closeup of two hands with gloves holding some test tubes
Filters:
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

PharmNovo at Biostock

December 22, 2022
No items found.

CEO Per von Mentzer presented PharmNovo at the BioStock - Connecting Innovation and Capital Life Science Fall Summit 2022. Watch his presentation addressing the large, unmet medical needs in the neuropathic pain market and learn more about our ongoing clinical trial and how we will achieve project milestones as PharmNovo moves forward.

Read more →

Seasons Greetings 2022

December 22, 2022
No items found.

The PharmNovo team would like to wish you a Merry Christmas and a Happy New Year!

Read more →

Strengthening the team

October 11, 2022
New Member

PharmNovo has strengthened the team with a new experienced Project Manager and a Clinical Trial Manager

Read more →

Good press in SvD

September 20, 2022
No items found.

Read the story about PharmNovo and our drug candidate PN6047 for neurophatic pain and its ongoing phase I studies in Svenska Dagbladet.

Read more →

OP Team steps up

September 5, 2022
No items found.

PharmNovo appoints CFO and Clinical lead to strengthen the organization.

Read more →

Phase I study initiated

August 19, 2022
No items found.

We are pleased to inform that during the summer, the application to start

Read more →

No results found

FacebookLinkedInContact
PharmNovo ©
Privacy Policy

By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Awesome 👌